Business Context and Reporting Period
Company: Profound Medical Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: July 15, 2026
Reporting Period: Single event date (July 15, 2026)
Business Context: The Company is a medical technology firm focused on the TULSA Procedure™. This filing serves as a Regulation FD disclosure regarding upcoming presentations at a major industry conference.
Key Financial Metrics
This Form 8-K is a current report regarding a specific event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely announces a scheduled marketing and educational activity.
Guidance, Outlook, and Management Commentary
- Event Announcement: The Company announced that its TULSA Procedure™ will be highlighted in several presentations at the Society of Robotic Surgery Annual Meeting.
- Event Details: The meeting is scheduled for July 23-26, 2026, in Fort Lauderdale, FL.
- Regulatory Note: The information provided, including the press release (Exhibit 99.1), is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the content of the press release (Exhibit 99.1) for specific details on the TULSA Procedure™ presentations.
- Confirm the schedule and agenda of the Society of Robotic Surgery Annual Meeting for July 23-26, 2026.
- Review subsequent filings (e.g., 10-Q or 10-K) for actual financial performance data, as this 8-K contains no financial metrics.